Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;11(2):112-28.
doi: 10.1038/nrendo.2014.202. Epub 2014 Nov 25.

Gastric emptying and glycaemia in health and diabetes mellitus

Affiliations
Review

Gastric emptying and glycaemia in health and diabetes mellitus

Liza K Phillips et al. Nat Rev Endocrinol. 2015 Feb.

Abstract

The rate of gastric emptying is a critical determinant of postprandial glycaemia and, accordingly, is fundamental to maintaining blood glucose homeostasis. Disordered gastric emptying occurs frequently in patients with longstanding type 1 diabetes mellitus and type 2 diabetes mellitus (T2DM). A complex bidirectional relationship exists between gastric emptying and glycaemia--gastric emptying accounts for ∼35% of the variance in peak postprandial blood glucose concentrations in healthy individuals and in patients with diabetes mellitus, and the rate of emptying is itself modulated by acute changes in glycaemia. Clinical implementation of incretin-based therapies for the management of T2DM, which diminish postprandial glycaemia, in part by slowing gastric emptying, is widespread. Other therapies for patients with T2DM, which specifically target gastric emptying include pramlintide and dietary-based treatment approaches. A weak association exists between upper gastrointestinal symptoms and the rate of gastric emptying. In patients with severe diabetic gastroparesis, pathological changes are highly variable and are characterized by loss of interstitial cells of Cajal and an immune infiltrate. Management options for patients with symptomatic gastroparesis remain limited in their efficacy, which probably reflects the heterogeneous nature of the underlying pathophysiology.

PubMed Disclaimer

References

    1. Neurogastroenterol Motil. 2006 Jun;18(6):405-7 - PubMed
    1. Am J Gastroenterol. 2008 Feb;103(2):416-23 - PubMed
    1. Eur Radiol. 2010 Nov;20(11):2609-16 - PubMed
    1. N Engl J Med. 1993 Sep 30;329(14):977-86 - PubMed
    1. Aliment Pharmacol Ther. 2006 Aug 15;24(4):661-7 - PubMed

MeSH terms

Substances

LinkOut - more resources